$PMT
PennyMac Mortgage Investment Trust Stock $pmt

$pmt Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000156459017009925 Filed on May 09, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016 Q1
Revenue	$64.47M	$68.93M	$52.22M
YoY Change	23.48%	36.3%	38.66%
Cost Of Revenue	$71.10M	$92.60M	$64.00M
YoY Change	11.09%	28.08%	13.68%
Gross Profit	$30.50M	$17.20M	$20.30M
YoY Change	50.25%	75.51%	185.92%
Gross Profit Margin	47.31%	24.95%	38.88%
Selling, General & Admin	$3.300M	$3.400M	$3.600M
YoY Change	-8.33%	-8.11%	-21.74%
% of Gross Profit	10.82%	19.77%	17.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$41.87M	$3.300M	$41.17M
YoY Change	1.69%	17.86%	-0.74%
Operating Profit	-$11.37M	$13.90M	-$20.87M
YoY Change	-45.54%	98.57%	-39.28%
Interest Expense	$37.18M		$32.00M
YoY Change	16.17%		24.31%
% of Operating Profit
Other Income/Expense, Net	$3.503M		$4.515M
YoY Change	-22.41%		-7.04%
Pretax Income	$22.61M	$13.90M	$11.04M
YoY Change	104.71%	101.45%	-389.11%
Income Tax	-$6.129M	-$17.30M	-$3.452M
% Of Pretax Income	-27.11%	-124.46%	-31.26%
Net Earnings	$28.74M	$31.17M	$14.50M
YoY Change	98.24%	98.45%	93.07%
Net Earnings / Revenue	44.57%	45.23%	27.76%
Basic Earnings Per Share	$0.42	$0.46	$0.20
Diluted Earnings Per Share	$0.40	$0.44	$0.20
COMMON SHARES
Basic Shares Outstanding	66.72M	66.70M	71.88M
Diluted Shares Outstanding	75.19M		71.88M

Balance Sheet

Concept	2017 Q1	2016 Q4	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$120.0M	$34.00M	$67.00M
YoY Change	79.1%	-41.38%	1.52%
Cash & Equivalents	$120.0M	$34.48M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$201.0M	$118.0M	$150.0M
YoY Change	34.0%	-23.87%	-0.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.00M	$29.00M	$13.00M
YoY Change	176.92%	222.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.851B	$0.00	$734.0M
YoY Change	152.18%		25.68%
Other Assets
YoY Change
Total Long-Term Assets	$5.802B	$6.240B	$5.670B
YoY Change	2.32%	10.01%	1.63%
TOTAL ASSETS
Total Short-Term Assets	$201.0M	$118.0M	$150.0M
Total Long-Term Assets	$5.802B	$6.240B	$5.670B
Total Assets	$6.003B	$6.358B	$5.820B
YoY Change	3.14%	9.11%	1.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.00M	$16.00M	$18.00M
YoY Change	16.67%	-15.79%	-5.26%
Accrued Expenses	$5.000M	$4.000M	$1.000M
YoY Change	400.0%
Deferred Revenue
YoY Change
Short-Term Debt	$3.634B	$3.934B	$150.0M
YoY Change	2322.93%	2522.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.747B	$3.972B	$253.0M
YoY Change	1381.03%	929.02%	328.81%
LONG-TERM LIABILITIES
Long-Term Debt	$760.0M	$901.0M	$859.0M
YoY Change	-11.53%	23.59%	77.48%
Other Long-Term Liabilities	$17.00M	$25.00M	$3.277B
YoY Change	-99.48%	-99.21%	-8.49%
Total Long-Term Liabilities	$777.0M	$926.0M	$4.136B
YoY Change	-81.21%	-76.14%	1.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.747B	$3.972B	$253.0M
Total Long-Term Liabilities	$777.0M	$926.0M	$4.136B
Total Liabilities	$4.544B	$5.006B	$4.406B
YoY Change	3.14%	15.6%	5.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.64M	-$26.72M	$7.466M
YoY Change	-497.0%	-204.17%	-87.38%
Common Stock	$1.488B	$1.378B	$1.407B
YoY Change	5.77%	-6.3%	-5.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.459B	$1.351B	$1.415B
YoY Change
Total Liabilities & Shareholders Equity	$6.003B	$6.358B	$5.820B
YoY Change	3.14%	9.11%	1.57%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016 Q1
OPERATING ACTIVITIES
Net Income	$28.74M	$31.17M	$14.50M
YoY Change	98.24%	98.45%	93.07%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$395.4M	$170.2M	-$39.60M
YoY Change	-1098.48%	-150.5%	-94.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$42.00M	$25.80M	$93.10M
YoY Change	-54.89%	-68.03%	-201.97%
Cash From Investing Activities	$42.00M	$25.80M	$93.10M
YoY Change	-54.89%	-68.03%	-201.97%
FINANCING ACTIVITIES
Cash Dividend Paid	$31.66M		$34.99M
YoY Change	-9.54%		-23.75%
Common Stock Issuance & Retirement, Net	$2.307M		$64.47M
YoY Change	-96.42%		-805987.5%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-351.8M	-300.4M	-44.60M
YoY Change	688.79%	-233.51%	-105.35%
NET CHANGE
Cash From Operating Activities	395.4M	170.2M	-39.60M
Cash From Investing Activities	42.00M	25.80M	93.10M
Cash From Financing Activities	-351.8M	-300.4M	-44.60M
Net Change In Cash	85.60M	-104.4M	8.900M
YoY Change	861.8%	233.55%	-183.96%
FREE CASH FLOW
Cash From Operating Activities	$395.4M	$170.2M	-$39.60M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2017Q1	us-gaap	Assets Assets	6002946000
CY2016Q4	us-gaap	Assets Assets	6357502000
CY2017Q1	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	3500190000
CY2017Q1	us-gaap	Real Estate Investments RealEstateInvestments	35537000
CY2016Q4	us-gaap	Real Estate Investments RealEstateInvestments	29324000
CY2016Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	3784001000
CY2017Q1	us-gaap	Servicing Asset ServicingAsset	696970000
CY2016Q4	us-gaap	Servicing Asset ServicingAsset	656567000
CY2017Q1	pmt	Servicing Advances ServicingAdvances	70332000
CY2016Q4	pmt	Servicing Advances ServicingAdvances	76950000
CY2017Q1	us-gaap	Other Assets OtherAssets	90488000
CY2016Q4	us-gaap	Other Assets OtherAssets	124586000
CY2017Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	224831000
CY2016Q4	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	353898000
CY2017Q1	us-gaap	Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	1089610000
CY2016Q4	us-gaap	Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment	863802000
CY2016Q4	pmt	Pledged Assets Separately Reported Loans Acquired For Sale Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedLoansAcquiredForSalePledgedAsCollateralAtFairValue	1653748000
CY2017Q1	us-gaap	Pledged Assets Separately Reported Loans Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedLoansPledgedAsCollateralAtFairValue	1578065000
CY2016Q4	us-gaap	Pledged Assets Separately Reported Loans Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedLoansPledgedAsCollateralAtFairValue	1712190000
CY2017Q1	pmt	Derivative Assets Pledged To Creditors DerivativeAssetsPledgedToCreditors	13689000
CY2016Q4	pmt	Derivative Assets Pledged To Creditors DerivativeAssetsPledgedToCreditors	9078000
CY2016Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	64136000
CY2017Q1	pmt	Servicing Asset Pledged To Creditors ServicingAssetPledgedToCreditors	686759000
CY2016Q4	pmt	Servicing Asset Pledged To Creditors ServicingAssetPledgedToCreditors	656567000
CY2017Q1	us-gaap	Interest Income Operating InterestIncomeOperating	48100000
CY2016Q1	us-gaap	Interest Income Operating InterestIncomeOperating	54366000
CY2017Q1	pmt	Net Results Of Real Estate Acquired In Settlement Of Loans NetResultsOfRealEstateAcquiredInSettlementOfLoans	-4246000
CY2017Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1892000
CY2016Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1289000
CY2017Q1	us-gaap	Loan Processing Fee LoanProcessingFee	1512000
CY2016Q1	us-gaap	Loan Processing Fee LoanProcessingFee	1121000
CY2017Q1	pmt	Mortgage Loan Collection And Liquidation Expenses MortgageLoanCollectionAndLiquidationExpenses	354000
CY2016Q1	pmt	Mortgage Loan Collection And Liquidation Expenses MortgageLoanCollectionAndLiquidationExpenses	2214000
CY2017Q1	us-gaap	Other Expenses OtherExpenses	4591000
CY2016Q1	us-gaap	Other Expenses OtherExpenses	4515000
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	41866000
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	41172000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22608000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11044000
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6129000
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3452000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	28737000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	14496000
CY2017Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	571000
CY2016Q4	us-gaap	Deposits Assets DepositsAssets	450059000
CY2017Q1	pmt	Pledged Assets Separately Reported Loans Acquired For Sale Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedLoansAcquiredForSalePledgedAsCollateralAtFairValue	1257927000
CY2016Q4	us-gaap	Notes Payable NotesPayable	275106000
CY2016Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	274069000
CY2017Q1	us-gaap	Deposits Assets DepositsAssets	463836000
CY2016Q4	pmt	Mortgage Loan Participation And Sale Agreement MortgageLoanParticipationAndSaleAgreement	25917000
CY2017Q1	us-gaap	Notes Payable NotesPayable	100088000
CY2017Q1	pmt	Asset Backed Secured Financing Liability Fair Value AssetBackedSecuredFinancingLiabilityFairValue	340365000
CY2017Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	5352000
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	9573000
CY2017Q1	pmt	Deposits Pledged To Creditors DepositsPledgedToCreditors	412594000
CY2016Q4	pmt	Deposits Pledged To Creditors DepositsPledgedToCreditors	414610000
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66711052
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	46000
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	667000
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66697286
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66711052
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66697286
CY2017Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	19025000
CY2016Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	15049000
CY2017Q1	pmt	Loan Originations Fees LoanOriginationsFees	8290000
CY2016Q1	pmt	Loan Originations Fees LoanOriginationsFees	6901000
CY2017Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	16721000
CY2016Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3898000
CY2017Q1	us-gaap	Servicing Fees Net ServicingFeesNet	11752000
CY2016Q1	us-gaap	Servicing Fees Net ServicingFeesNet	15554000
CY2017Q1	us-gaap	Interest Expense InterestExpense	37179000
CY2016Q1	us-gaap	Interest Expense InterestExpense	32004000
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10921000
CY2016Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	22362000
CY2016Q1	pmt	Net Results Of Real Estate Acquired In Settlement Of Loans NetResultsOfRealEstateAcquiredInSettlementOfLoans	-6036000
CY2017Q1	us-gaap	Other Income OtherIncome	2011000
CY2016Q1	us-gaap	Other Income OtherIncome	2284000
CY2017Q1	us-gaap	Revenues Revenues	64474000
CY2016Q1	us-gaap	Revenues Revenues	52216000
CY2017Q1	pmt	Loan Fulfillment Fees Payable To Affiliate LoanFulfillmentFeesPayableToAffiliate	16570000
CY2016Q1	pmt	Loan Fulfillment Fees Payable To Affiliate LoanFulfillmentFeesPayableToAffiliate	12935000
CY2017Q1	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	10486000
CY2016Q1	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	11453000
CY2017Q1	us-gaap	Management Fee Expense ManagementFeeExpense	5008000
CY2016Q1	us-gaap	Management Fee Expense ManagementFeeExpense	5352000
CY2017Q1	us-gaap	Professional Fees ProfessionalFees	1453000
CY2016Q1	us-gaap	Professional Fees ProfessionalFees	2293000
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	667000
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1487517000
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	1458590000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1351114000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6357502000
CY2017Q1	pmt	Mortgage Loan Participation And Sale Agreement MortgageLoanParticipationAndSaleAgreement	72975000
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1377171000
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29640000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26724000
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6002946000
CY2016Q4	pmt	Representations And Warranties Liability RepresentationsAndWarrantiesLiability	15350000
CY2017Q1	us-gaap	Liabilities Liabilities	4544356000
CY2016Q4	us-gaap	Liabilities Liabilities	5006388000
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	80219000
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	107758000
CY2017Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	12006000
CY2016Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	18166000
CY2017Q1	pmt	Representations And Warranties Liability RepresentationsAndWarrantiesLiability	11447000
CY2017Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	69683000
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0
CY2017Q1	pmt	Net Income Loss Attributable To Common Stockholders NetIncomeLossAttributableToCommonStockholders	28166000
CY2016Q1	pmt	Net Income Loss Attributable To Common Stockholders NetIncomeLossAttributableToCommonStockholders	14496000
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66719000
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71884000
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75186000
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71884000
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1496113000
CY2016Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1048000
CY2016Q1	us-gaap	Dividends Common Stock DividendsCommonStock	32683000
CY2016Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	64471000
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	1414503000
CY2017Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1527000
CY2017Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	115000000
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3828000
CY2017Q1	us-gaap	Dividends Common Stock DividendsCommonStock	31653000
CY2017Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2307000
CY2017Q1	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	27046000
CY2016Q1	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	13448000
CY2017Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1406000
CY2016Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	6060000
CY2017Q1	pmt	Capitalization Of Interest And Advances On Mortgage Loans At Fair Value CapitalizationOfInterestAndAdvancesOnMortgageLoansAtFairValue	9903000
CY2016Q1	pmt	Capitalization Of Interest And Advances On Mortgage Loans At Fair Value CapitalizationOfInterestAndAdvancesOnMortgageLoansAtFairValue	23294000
CY2017Q1	pmt	Capitalization Of Interest On Excess Servicing Spread CapitalizationOfInterestOnExcessServicingSpread	4647000
CY2016Q1	pmt	Capitalization Of Interest On Excess Servicing Spread CapitalizationOfInterestOnExcessServicingSpread	7015000
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3596000
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3201000
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1527000
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1048000
CY2017Q1	pmt	Payments To Purchase Mortgage Loans Held For Sale Nonaffiliates PaymentsToPurchaseMortgageLoansHeldForSaleNonaffiliates	14474654000
CY2016Q1	pmt	Payments To Purchase Mortgage Loans Held For Sale Nonaffiliates PaymentsToPurchaseMortgageLoansHeldForSaleNonaffiliates	10149221000
CY2017Q1	pmt	Payments To Purchase Mortgage Loans Held For Sale Affiliates PaymentsToPurchaseMortgageLoansHeldForSaleAffiliates	21530000
CY2016Q1	pmt	Payments To Purchase Mortgage Loans Held For Sale Affiliates PaymentsToPurchaseMortgageLoansHeldForSaleAffiliates	4715000
CY2017Q1	pmt	Proceeds From Repurchase Of Mortgage Loans Subject To Representation And Warranties ProceedsFromRepurchaseOfMortgageLoansSubjectToRepresentationAndWarranties	-4111000
CY2016Q1	pmt	Proceeds From Repurchase Of Mortgage Loans Subject To Representation And Warranties ProceedsFromRepurchaseOfMortgageLoansSubjectToRepresentationAndWarranties	-3844000
CY2017Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4858845000
CY2016Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	3233779000
CY2017Q1	pmt	Proceeds From Sale Of Mortgage Loans Held For Sale To Affiliates ProceedsFromSaleOfMortgageLoansHeldForSaleToAffiliates	10016788000
CY2016Q1	pmt	Proceeds From Sale Of Mortgage Loans Held For Sale To Affiliates ProceedsFromSaleOfMortgageLoansHeldForSaleToAffiliates	6853542000
CY2017Q1	pmt	Increase Decrease In Servicing Advances IncreaseDecreaseInServicingAdvances	-6187000
CY2016Q1	pmt	Increase Decrease In Servicing Advances IncreaseDecreaseInServicingAdvances	-9080000
CY2017Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	3995000
CY2016Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-2186000
CY2017Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-30948000
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-24088000
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-27536000
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9771000
CY2017Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	4340000
CY2016Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-1318000
CY2017Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-6161000
CY2016Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-3627000
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	395383000
CY2017Q1	pmt	Proceeds From Issuance Of Mortgage Loan Participation Certificates ProceedsFromIssuanceOfMortgageLoanParticipationCertificates	1559494000
CY2016Q1	pmt	Proceeds From Issuance Of Mortgage Loan Participation Certificates ProceedsFromIssuanceOfMortgageLoanParticipationCertificates	1567101000
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-39570000
CY2017Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-102205000
CY2016Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	5635000
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	251872000
CY2016Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	50702000
CY2017Q1	pmt	Proceeds From Sale And Repayments Of Mortgage Backed Securities Mbs At Fair Value ProceedsFromSaleAndRepaymentsOfMortgageBackedSecuritiesMbsAtFairValue	26123000
CY2016Q1	pmt	Proceeds From Sale And Repayments Of Mortgage Backed Securities Mbs At Fair Value ProceedsFromSaleAndRepaymentsOfMortgageBackedSecuritiesMbsAtFairValue	13848000
CY2017Q1	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	127556000
CY2016Q1	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	47865000
CY2017Q1	pmt	Repayments Of Excess Servicing Spread Investment RepaymentsOfExcessServicingSpreadInvestment	14632000
CY2016Q1	pmt	Repayments Of Excess Servicing Spread Investment RepaymentsOfExcessServicingSpreadInvestment	20881000
CY2017Q1	pmt	Proceeds From The Sale Of Excess Servicing Spread ProceedsFromTheSaleOfExcessServicingSpread	0
CY2016Q1	pmt	Proceeds From The Sale Of Excess Servicing Spread ProceedsFromTheSaleOfExcessServicingSpread	59045000
CY2017Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	28000
CY2016Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	2000
CY2017Q1	pmt	Proceeds From Sale Of Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfRealEstateAcquiredInSettlementOfLoans	63224000
CY2016Q1	pmt	Proceeds From Sale Of Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfRealEstateAcquiredInSettlementOfLoans	64908000
CY2017Q1	us-gaap	Payments To Acquire Mortgage Servicing Rights Msr PaymentsToAcquireMortgageServicingRightsMSR	62000
CY2016Q1	us-gaap	Payments To Acquire Mortgage Servicing Rights Msr PaymentsToAcquireMortgageServicingRightsMSR	2602000
CY2017Q1	pmt	Deposits Of Cash Securing Credit Risk Transfer Agreements DepositsOfCashSecuringCreditRiskTransferAgreements	15793000
CY2016Q1	pmt	Deposits Of Cash Securing Credit Risk Transfer Agreements DepositsOfCashSecuringCreditRiskTransferAgreements	66706000
CY2017Q1	pmt	Distributions From Credit Risk Transfer Agreements DistributionsFromCreditRiskTransferAgreements	12305000
CY2016Q1	pmt	Distributions From Credit Risk Transfer Agreements DistributionsFromCreditRiskTransferAgreements	2706000
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	36267000
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-2368000
CY2017Q1	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	0
CY2016Q1	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	225000
CY2017Q1	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	0
CY2016Q1	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	7320000
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	42023000
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	93069000
CY2017Q1	pmt	Proceeds From Sale Of Assets Under Agreements To Repurchase ProceedsFromSaleOfAssetsUnderAgreementsToRepurchase	17770687000
CY2016Q1	pmt	Proceeds From Sale Of Assets Under Agreements To Repurchase ProceedsFromSaleOfAssetsUnderAgreementsToRepurchase	11058933000
CY2017Q1	pmt	Repayments Of Assets Sold Under Agreements To Repurchase RepaymentsOfAssetsSoldUnderAgreementsToRepurchase	18054705000
CY2016Q1	pmt	Repayments Of Assets Sold Under Agreements To Repurchase RepaymentsOfAssetsSoldUnderAgreementsToRepurchase	10943166000
CY2017Q1	pmt	Repayments Of Mortgage Loan Participation Certificates RepaymentsOfMortgageLoanParticipationCertificates	1512435000
CY2016Q1	pmt	Repayments Of Mortgage Loan Participation Certificates RepaymentsOfMortgageLoanParticipationCertificates	1504700000
CY2017Q1	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	0
CY2016Q1	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	28000000
CY2017Q1	us-gaap	Payments For Federal Home Loan Bank Advances PaymentsForFederalHomeLoanBankAdvances	0
CY2016Q1	us-gaap	Payments For Federal Home Loan Bank Advances PaymentsForFederalHomeLoanBankAdvances	211000000
CY2017Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0
CY2016Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	17057000
CY2017Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	175000000
CY2016Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	46936000
CY2017Q1	pmt	Proceeds From Sale Of Asset Backed Secured Financing ProceedsFromSaleOfAssetBackedSecuredFinancing	0
CY2016Q1	pmt	Proceeds From Sale Of Asset Backed Secured Financing ProceedsFromSaleOfAssetBackedSecuredFinancing	100301000
CY2017Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	13944000
CY2016Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	8334000
CY2017Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3140000
CY2016Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2427000
CY2017Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	115000000
CY2016Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0
CY2017Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3828000
CY2016Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2307000
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	64471000
CY2017Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	31655000
CY2016Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	34993000
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-351833000
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-44635000
CY2017Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	85573000
CY2016Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	8864000
CY2015Q4	us-gaap	Cash Cash	58108000
CY2016Q1	us-gaap	Cash Cash	66972000
CY2017Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 32—Recently Issued Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">In May 2014, the FASB issued ASU 2014-09, <font style="font-style:italic;">Revenue from Contracts with Customers (Subtopic 606)</font> (“ASU 2014-09”), which supersedes the guidance in the <font style="font-style:italic;">Revenue Recognition </font>topic of the ASC. ASU 2014-09 clarifies the principles for recognizing revenue in order to improve comparability of revenue recognition practices across entities and industries with certain scope exceptions including financial instruments, leases, and guarantees. ASU 2014-09 provides guidance intended to assist in the identification of contracts with customers and separate performance obligations within those contracts, the determination and allocation of the transaction price to those identified performance obligations and the recognition of revenue when a performance obligation has been satisfied. ASU 2014-09 also requires disclosures regarding the nature, amount, timing, and uncertainty of revenues and cash flows from contracts with customers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption, ASU 2014-09 provides for transition through either a full retrospective approach requiring the restatement of all presented prior periods or a modified retrospective approach, which allows the new recognition standard to be applied to only those contracts that are not completed at the date of transition. If the modified retrospective approach is adopted, a cumulative-effect adjustment to retained earnings is performed with additional disclosures required including the amount by which each line item is affected by the transition as compared to the guidance in effect before adoption and an explanation of the reasons for significant changes in these amounts.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FASB has issued several amendments to ASU 2014-09, including:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2015, ASU 2015-14, <font style="font-style:italic;">Revenue From Contracts With Customers </font>(“ASU 2015-14”). This update deferred the initial effective date of ASU 2014-09. As a result of the issuance of ASU 2015-14, ASU 2014-09 is effective for annual reporting periods beginning on or after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, ASU 2016-08, <font style="font-style:italic;">Principal Versus Agent Considerations (Reporting Revenue Gross versus Net)</font>. The amendments to this update are intended to improve the implementation guidance on principal versus agent considerations in ASU 2014-09 by clarifying how an entity should identify the unit of accounting (i.e. the specified good or service) and how an entity should apply the control principle to certain types of arrangements.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2016, ASU 2016-12, <font style="font-style:italic;">Narrow-Scope Improvements and Practical Expedients</font>. The amendments to this update clarify certain core recognition principles and provide practical expedients available at transition. The improvements address collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2016, ASU 2016-20, <font style="font-style:italic;">Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers</font>. The amendments to this update:</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify that guarantee fees within the scope of the <font style="font-style:italic;">Guarantees</font> topic of the ASC (other than product or service warranties) are not within the scope of the <font style="font-style:italic;">Revenue from Contracts with Customers</font> topic of the ASC. Entities should see the <font style="font-style:italic;">Derivatives and Hedging</font> topic of the ASC, for guarantees accounted for as derivatives.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify the <font style="font-style:italic;">Other Assets and Deferred Costs—Contracts with Customers</font> subtopic of the ASC that when performing impairment testing an entity should (a) consider expected contract renewals and extensions and (b) include both the amount of consideration it already has received but has not recognized as revenue and the amount it expects to receive in the future.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify the interaction of impairment testing with guidance in other ASC topics that impairment testing first should be performed on assets not within the scope of the <font style="font-style:italic;">Other Assets and Deferred Costs</font>, <font style="font-style:italic;">Intangibles-Goodwill and Other </font>and the <font style="font-style:italic;">Property, Plant, and Equipment </font>topics (such as assets within the <font style="font-style:italic;">Inventory</font> topic of the ASC), then assets within the scope of the <font style="font-style:italic;">Other Assets and Deferred </font>Costs topic of the ASC, then asset groups and reporting units within the scope of the <font style="font-style:italic;">Other Assets and Deferred Costs</font>, <font style="font-style:italic;">Intangibles-Goodwill and Other</font> and the <font style="font-style:italic;">Property, Plant, and Equipment</font> topics of the ASC.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify that all contracts within the scope of the <font style="font-style:italic;">Financial Services – Insurance</font> topic of the ASC are excluded from the scope of the Revenue from Contracts with Customers topic.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provide optional exemptions from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue and expands the information that is required to be disclosed when an entity applies one of the optional exemptions.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clarify that the disclosure of revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods applies to all performance obligations and is not limited to performance obligations with corresponding contract balances.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2017, ASU 2017-05, <font style="font-style:italic;">Other Income—Gains and Losses from the Derecognition of</font> <font style="font-style:italic;">Nonfinancial Assets (Subtopic 610-20)</font> (“ASU 2017-05”). The amendments to this update clarify the scope of the <font style="font-style:italic;">Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets</font> subtopic of the ASC, and to add guidance for partial sales of nonfinancial assets. ASU 2017-05 clarifies that:</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A financial asset is within the scope of the <font style="font-style:italic;">Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets</font> subtopic of the ASC if it meets the definition of an in substance nonfinancial asset and defines the term in substance nonfinancial asset, in part, as a financial asset promised to a counterparty in a contract if substantially all of the fair value of the assets (recognized and unrecognized) that are promised to the counterparty in the contract is concentrated in nonfinancial assets.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It excludes all businesses and nonprofit activities from the scope of the <font style="font-style:italic;">Other Income – Gains and Losses from the Derecognition of Nonfinancial Assets</font> subtopic of the ASC. Derecognition of all businesses and nonprofit activities should be accounted for in accordance with the <font style="font-style:italic;">Consolidation—Overall</font> subtopic of the ASC.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An entity should identify each distinct nonfinancial asset or in substance nonfinancial asset promised to a counterparty and derecognize each asset when a counterparty obtains control of it. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An entity should allocate consideration to each distinct asset by applying the guidance in the <font style="font-style:italic;">Revenue from Contracts with Customers</font> topic of the ASC on allocating the transaction price to performance obligations.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:9.06%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Courier New';font-size:10pt;">o</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An entity must derecognize a distinct nonfinancial asset or distinct in substance nonfinancial asset in a partial sale transaction when it (1) does not have (or ceases to have) a controlling financial interest in the legal entity that holds the asset in accordance with the Consolidations topic and (2) transfers control of the asset in accordance with the <font style="font-style:italic;">Revenue from Contracts with Customers </font>topic of the ASC. Once an entity transfers control of a distinct nonfinancial asset or distinct in substance nonfinancial asset, it is required to measure any noncontrolling interest it receives (or retains) at fair value.</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Manager is currently evaluating the pending adoption of ASU 2014-09 and its amendments and their impact on the consolidated financial statements. The Manager does not expect the adoption of ASU 2014-09 to have a significant effect on the consolidated financial statements of the Company and has not yet identified which transition method will be applied upon adoption.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2016, the FASB issued ASU 2016-01, <font style="font-style:italic;">Financial Instruments–Overall: Recognition and Measurement of Financial Assets and Financial Liabilities</font> (“ASU 2016-01”). ASU 2016-01 affects the accounting for equity investments, financial liabilities under the fair value option, the presentation and disclosure requirements for financial instruments, and the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2016-01 requires that:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All equity investments in unconsolidated entities (other than those accounted for using the equity method of accounting) with readily determinable fair values will generally be measured at fair value through earnings.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When the fair value option has been elected for financial liabilities, changes in fair value due to instrument-specific credit risk will be recognized separately in other comprehensive income. The accumulated gains and losses due to these changes will be reclassified from accumulated other comprehensive income to earnings if the financial liability is settled before maturity.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For financial instruments measured at amortized cost, public business entities will be required to use the exit price when measuring the fair value of financial instruments for disclosure purposes.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial assets and financial liabilities shall be presented separately in the notes to the financial statements, grouped by measurement category (e.g., fair value, amortized cost, lower of cost or fair value) and form of financial asset (e.g., loans, securities).</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Public business entities will no longer be required to disclose the methods and significant assumptions used to estimate the fair value of financial instruments carried at amortized cost.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Entities will have to assess the realizability of a deferred tax asset related to a debt security classified as available for sale in combination with the entity’s other deferred tax assets.</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The classification and measurement guidance will be effective for public business entities in fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income is permitted and can be elected for all financial statements of fiscal years and interim periods that have not yet been issued or that have not yet been made available for issuance. The Manager does not believe that the adoption of ASU 2016-01 will have a significant effect on its consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the FASB issued ASU 2016-09, <font style="font-style:italic;">Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</font> (“ASU 2016-09”). ASU 2016-09 simplifies several aspects of the accounting for share-based payment award transactions, including:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Modifies the accounting for income taxes relating to share-based payments. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) will be recognized as income tax expense or benefit in the consolidated statement of income. The tax effects of exercised or vested awards will be treated as discrete items in the reporting period in which they occur. An entity will recognize excess tax benefits regardless of whether the benefit reduces taxes payable in the current period. Under current GAAP, excess tax benefits are recognized in additional paid-in capital; tax deficiencies are recognized either as an offset to accumulated excess tax benefits, if any, or in the consolidated statement of income in the period they reduce income taxes payable.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes the classification of excess tax benefits on the consolidated statement of cash flows. In the consolidated statement of cash flows, excess tax benefits will be classified along with other income tax cash flows as an operating activity. Under current GAAP, excess tax benefits are separated from other income tax cash flows and classified as a financing activity.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes the requirement to estimate the number of awards that are expected to vest. Under ASC 2016-09, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest as presently required or account for forfeitures when they occur. Under current GAAP, accruals of compensation cost are based on the number of awards that are expected to vest.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes the tax withholding requirements for share-based payment awards to qualify for equity accounting. The threshold to qualify for equity classification permits withholding up to the maximum statutory tax rates in the applicable jurisdictions. Under current GAAP, for an award to qualify for equity classification is that an entity cannot partially settle the award in cash in excess of the employer’s minimum statutory withholding requirements.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Establishes GAAP for the classification of employee taxes paid when an employer withholds shares for tax withholding purposes. Cash paid by an employer when directly withholding shares for tax- withholding purposes should be classified as a financing activity. This guidance establishes GAAP related to the classification of withholding taxes in the statement of cash flows as there is no such guidance under current GAAP.</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for any organization in any interim or annual period. The adoption ASU 2016-09 did not have a significant effect on the Company’s consolidated financial statements.</p></div>
CY2017Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Due to the nature of the Company’s investments, PMT is exposed, to a greater extent than traditional mortgage investors, to the risks associated with loan resolution, including that borrowers may be in economic distress and/or may have become unemployed, bankrupt or otherwise unable or unwilling to make payments when due, and that fluctuations in the residential real estate market may affect the performance of its investments. Factors influencing these risks include, but are not limited to:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changes in the overall economy, unemployment rates and residential real estate values in the markets where the properties securing the Company’s mortgage loans are located;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PCM’s ability to identify and PLS’ ability to execute optimal resolutions of certain mortgage loans;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the accuracy of valuation information obtained during the Company’s due diligence activities;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PCM’s ability to effectively model, and to develop appropriate model inputs that properly anticipate, future outcomes;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the level of government support for resolution of certain mortgage loans and the effect of current and future proposed and enacted legislative and regulatory changes on the Company’s ability to effect cures or resolutions to distressed mortgage loans; and</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">regulatory, judicial and legislative support of the foreclosure process, and the resulting effect on the Company’s ability to acquire and liquidate the real estate securing its portfolio of distressed mortgage loans in a timely manner or at all.</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to these uncertainties, there can be no assurance that risk management activities identified and executed on PMT’s behalf will prevent significant losses arising from the Company’s investments in real estate-related assets.</p></div>
CY2017Q1	pmt	Services Agreement Expiration Date ServicesAgreementExpirationDate	2020-09-12
CY2017Q1	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	<div> <p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Following is a summary of maturities of outstanding assets sold under agreements to repurchase by facility maturity date:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Remaining Maturity at March 31, 2017</font></p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual balance</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within 30 days</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,162,254</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 30 to 90 days</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">298,143</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 90 days to 180 days</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,017</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 180 days to 1 year</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">732,396</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over one year to two years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188,857</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:71%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,500,667</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:71%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average maturity (in months)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.62%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.7</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p></div>
CY2017Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2017Q1	pmt	Reit Qualification Threshold Percentage Of Taxable Income For Distribution ReitQualificationThresholdPercentageOfTaxableIncomeForDistribution	0.90
CY2017Q1	pmt	Fair Value Purchased Of Mortgage Loans Investment Portfolio Purchases From Or Through One Or More Subsidiaries FairValuePurchasedOfMortgageLoansInvestmentPortfolioPurchasesFromOrThroughOneOrMoreSubsidiaries	1082824000
CY2016	pmt	Fair Value Purchased Of Mortgage Loans Investment Portfolio Purchases From Or Through One Or More Subsidiaries FairValuePurchasedOfMortgageLoansInvestmentPortfolioPurchasesFromOrThroughOneOrMoreSubsidiaries	1192650000
CY2017Q1	pmt	Fair Value Of Distressed Mortgage Loans Purchased And Reo Held FairValueOfDistressedMortgageLoansPurchasedAndReoHeld	1454384000
CY2016Q4	pmt	Fair Value Of Distressed Mortgage Loans Purchased And Reo Held FairValueOfDistressedMortgageLoansPurchasedAndReoHeld	1628641000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	3784001000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	0
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	9573000
CY2017Q1	pmt	Fair Value Option Loans Held As Assets Aggregate Fair Value FairValueOptionLoansHeldAsAssetsAggregateFairValue	1583356000
CY2016Q4	pmt	Fair Value Option Loans Held As Assets Aggregate Fair Value FairValueOptionLoansHeldAsAssetsAggregateFairValue	1721741000
CY2017Q1	us-gaap	Mortgage Loans On Real Estate Principal Amount Of Delinquent Loans MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans	2025827000
CY2016Q4	us-gaap	Mortgage Loans On Real Estate Principal Amount Of Delinquent Loans MortgageLoansOnRealEstatePrincipalAmountOfDelinquentLoans	2208183000
CY2017Q1	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	-442471000
CY2016Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	-486442000
CY2017Q1	pmt	Service Agreement Maturity Renewal Term ServiceAgreementMaturityRenewalTerm	P18M
CY2017Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	298000
CY2016Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	412000
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	27868000
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14084000
CY2017Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	27868000
CY2016Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	14084000
CY2017Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2186000
CY2016Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	30054000
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14084000
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8467000
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	59684000
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	71093000
CY2017Q1	pmt	Derivative Asset Netting DerivativeAssetNetting	18471000
CY2016Q4	pmt	Derivative Asset Netting DerivativeAssetNetting	37384000
CY2017Q1	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0
CY2017Q1	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	0
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	41213000
CY2016Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0
CY2016Q4	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	0
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	33709000
CY2017Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3525597000
CY2017Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	20055000
CY2017Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3505542000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3812886000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	19312000
CY2016Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3793574000
CY2017Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	3500190000
CY2017Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	0
CY2017Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	5352000
CY2017Q1	pmt	Mortgage Loans Description MortgageLoansDescription	Note interest rate pools of 50 basis points
CY2017Q1	pmt	Basis Point For Mortgage Loan BasisPointForMortgageLoan	0.0050
CY2017Q1	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	244000000
CY2015Q4	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	240700000
CY2017Q1	pmt	Servicing Asset At Fair Value Additions From Loan Sales ServicingAssetAtFairValueAdditionsFromLoanSales	7478000
CY2016Q1	pmt	Servicing Asset At Fair Value Additions From Loan Sales ServicingAssetAtFairValueAdditionsFromLoanSales	3300000
CY2017Q1	pmt	Fair Value Unpaid Principal Balance Of Underlying Loans FairValueUnpaidPrincipalBalanceOfUnderlyingLoans	660586000
CY2016Q1	pmt	Fair Value Unpaid Principal Balance Of Underlying Loans FairValueUnpaidPrincipalBalanceOfUnderlyingLoans	327025000
CY2017Q1	pmt	Services Fee Annual Rate ServicesFeeAnnualRate	0.0025
CY2016Q1	pmt	Services Fee Annual Rate ServicesFeeAnnualRate	0.0026
CY2017Q1	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	51210000
CY2016Q1	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	32862000
CY2017Q1	pmt	Fair Value Unpaid Principal Of Underlying Loans Balance FairValueUnpaidPrincipalOfUnderlyingLoansBalance	6195339000
CY2016Q4	pmt	Fair Value Unpaid Principal Of Underlying Loans Balance FairValueUnpaidPrincipalOfUnderlyingLoansBalance	5763957000
CY2017Q1	pmt	Annual Service Fee Rate AnnualServiceFeeRate	0.0025
CY2016Q1	pmt	Percentage Of Amortized Cost PercentageOfAmortizedCost	0.0025
CY2016Q4	pmt	Annual Service Fee Rate AnnualServiceFeeRate	0.0025
CY2017Q1	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoans	4092267000
CY2016Q1	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoans	2759545000
CY2017Q1	pmt	Percentage Of Amortized Cost PercentageOfAmortizedCost	0.0025
CY2017Q1	pmt	Fair Value Weighted Average Coupon Interest Rate FairValueWeightedAverageCouponInterestRate	0.047
CY2016	pmt	Fair Value Weighted Average Coupon Interest Rate FairValueWeightedAverageCouponInterestRate	0.047
CY2017Q1	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	627287000
CY2016Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	592431000
CY2017Q1	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans Period End AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoansPeriodEnd	53355108000
CY2016	pmt	Amortized Cost Unpaid Principal Balance Of Underlying Loans Period End AmortizedCostUnpaidPrincipalBalanceOfUnderlyingLoansPeriodEnd	50539707000
CY2017Q1	pmt	Weighted Average Servicing Fee Rate Amortized Cost WeightedAverageServicingFeeRateAmortizedCost	0.0025
CY2016	pmt	Weighted Average Servicing Fee Rate Amortized Cost WeightedAverageServicingFeeRateAmortizedCost	0.0025
CY2017Q1	pmt	Amortized Cost Weighted Average Coupon Interest Rate AmortizedCostWeightedAverageCouponInterestRate	0.038
CY2016	pmt	Amortized Cost Weighted Average Coupon Interest Rate AmortizedCostWeightedAverageCouponInterestRate	0.038
CY2017Q1	pmt	Pledged Financial Instruments Not Separately Reported And Assets Separately Reported On Statement At Fair Value PledgedFinancialInstrumentsNotSeparatelyReportedAndAssetsSeparatelyReportedOnStatementAtFairValue	1257927000
CY2016Q4	pmt	Pledged Financial Instruments Not Separately Reported And Assets Separately Reported On Statement At Fair Value PledgedFinancialInstrumentsNotSeparatelyReportedAndAssetsSeparatelyReportedOnStatementAtFairValue	1653748000
CY2017Q1	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	18471000
CY2016Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	37384000
CY2017Q1	pmt	Margin Deposit Assets Liabilities MarginDepositAssetsLiabilities	1583000
CY2016Q4	pmt	Margin Deposit Assets Liabilities MarginDepositAssetsLiabilities	-18071000
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	25407000
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	28885000
CY2017Q1	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	20055000
CY2016Q4	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	19312000
CY2017Q1	pmt	Mortgage Loans On Real Estate Unpaid Balance MortgageLoansOnRealEstateUnpaidBalance	2025827000
CY2016Q4	pmt	Mortgage Loans On Real Estate Unpaid Balance MortgageLoansOnRealEstateUnpaidBalance	2208183000
CY2017Q1	pmt	Mortgage Loans At Fair Value Held By Variable Interest Entity MortgageLoansAtFairValueHeldByVariableInterestEntity	353803000
CY2016Q4	pmt	Mortgage Loans At Fair Value Held By Variable Interest Entity MortgageLoansAtFairValueHeldByVariableInterestEntity	367169000
CY2017Q1	pmt	Percentage Of Mortgage Loan Portfolio PercentageOfMortgageLoanPortfolio	0.73
CY2016Q4	pmt	Percentage Of Mortgage Loan Portfolio PercentageOfMortgageLoanPortfolio	0.72
CY2017Q1	pmt	Percentage Of Fair Value Mortgage Loan Portfolio PercentageOfFairValueMortgageLoanPortfolio	0.41
CY2016Q4	pmt	Percentage Of Fair Value Mortgage Loan Portfolio PercentageOfFairValueMortgageLoanPortfolio	0.41
CY2017Q1	pmt	Ratio Of Loans With Unpaid Principal Balance To Current Property Value RatioOfLoansWithUnpaidPrincipalBalanceToCurrentPropertyValue	1.00
CY2016Q4	pmt	Ratio Of Loans With Unpaid Principal Balance To Current Property Value RatioOfLoansWithUnpaidPrincipalBalanceToCurrentPropertyValue	1.00
CY2017Q1	pmt	Percentage Of Estimated Fair Value Of Mortgage Loans Originated PercentageOfEstimatedFairValueOfMortgageLoansOriginated	0.05
CY2016Q4	pmt	Percentage Of Estimated Fair Value Of Mortgage Loans Originated PercentageOfEstimatedFairValueOfMortgageLoansOriginated	0.05
CY2015Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	341846000
CY2017Q1	pmt	Real Estate Acquired In Satisfaction Of Debt RealEstateAcquiredInSatisfactionOfDebt	24876000
CY2016Q1	pmt	Real Estate Acquired In Satisfaction Of Debt RealEstateAcquiredInSatisfactionOfDebt	60494000
CY2017Q1	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	6644000
CY2016Q1	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	4184000
CY2017Q1	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-8175000
CY2016Q1	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-10645000
CY2017Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3929000
CY2016Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	4609000
CY2017Q1	pmt	Gains Losses Real Estate Owned Net GainsLossesRealEstateOwnedNet	-4246000
CY2016Q1	pmt	Gains Losses Real Estate Owned Net GainsLossesRealEstateOwnedNet	-6036000
CY2017Q1	us-gaap	Sales Of Real Estate SalesOfRealEstate	63224000
CY2016Q1	us-gaap	Sales Of Real Estate SalesOfRealEstate	64908000
CY2016Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	327212000
CY2017Q1	pmt	Real Estate Acquired Through Foreclosure Pledged To Secure Borrowings RealEstateAcquiredThroughForeclosurePledgedToSecureBorrowings	111594000
CY2016Q4	pmt	Real Estate Acquired Through Foreclosure Pledged To Secure Borrowings RealEstateAcquiredThroughForeclosurePledgedToSecureBorrowings	167430000
CY2017Q1	pmt	Real Estate Owned Held In Subsidiary For Financing Purposes RealEstateOwnedHeldInSubsidiaryForFinancingPurposes	60159000
CY2016Q4	pmt	Real Estate Owned Held In Subsidiary For Financing Purposes RealEstateOwnedHeldInSubsidiaryForFinancingPurposes	48283000
CY2017Q1	us-gaap	Pledged Assets Separately Reported Real Estate Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedRealEstatePledgedAsCollateralAtFairValue	171753000
CY2016Q4	us-gaap	Pledged Assets Separately Reported Real Estate Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedRealEstatePledgedAsCollateralAtFairValue	215713000
CY2016Q4	pmt	Servicing Asset At Amortized Cost Before Valuation Allowance ServicingAssetAtAmortizedCostBeforeValuationAllowance	606103000
CY2015Q4	pmt	Servicing Asset At Amortized Cost Before Valuation Allowance ServicingAssetAtAmortizedCostBeforeValuationAllowance	404101000
CY2017Q1	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	17858000
CY2016Q1	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	14287000
CY2017Q1	pmt	Servicing Asset At Amortized Cost Before Valuation Allowance ServicingAssetAtAmortizedCostBeforeValuationAllowance	639455000
CY2016Q1	pmt	Servicing Asset At Amortized Cost Before Valuation Allowance ServicingAssetAtAmortizedCostBeforeValuationAllowance	422676000
CY2016Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	13672000
CY2015Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	10944000
CY2017Q1	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions Recoveries ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisionsRecoveries	-1504000
CY2016Q1	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Provisions Recoveries ValuationAllowanceForImpairmentOfRecognizedServicingAssetsProvisionsRecoveries	17706000
CY2017Q1	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	12168000
CY2016Q1	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	28650000
CY2016Q1	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	394026000
CY2016Q4	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	626334000
CY2015Q4	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	424154000
CY2017Q1	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	662584000
CY2016Q1	us-gaap	Servicing Asset At Amortized Value Fair Value ServicingAssetAtAmortizedValueFairValue	405635000
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	72142000
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	66916000
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	61375000
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	55998000
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	50657000
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	332367000
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	639455000
CY2015Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	66584000
CY2017Q1	pmt	Mortgage Servicing Rights Fair Value Purchases MortgageServicingRightsFairValuePurchases	62000
CY2016Q1	pmt	Mortgage Servicing Rights Fair Value Purchases MortgageServicingRightsFairValuePurchases	2602000
CY2017Q1	us-gaap	Servicing Asset At Fair Value Changes In Fair Value Resulting From Changes In Valuation Inputs Or Changes In Assumptions ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions	32000
CY2016Q1	us-gaap	Servicing Asset At Fair Value Changes In Fair Value Resulting From Changes In Valuation Inputs Or Changes In Assumptions ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions	-8952000
CY2017Q1	us-gaap	Servicing Asset At Fair Value Other Changes In Fair Value ServicingAssetAtFairValueOtherChangesInFairValue	-2025000
CY2016Q1	us-gaap	Servicing Asset At Fair Value Other Changes In Fair Value ServicingAssetAtFairValueOtherChangesInFairValue	-2463000
CY2017Q1	us-gaap	Servicing Asset At Fair Value Period Increase Decrease ServicingAssetAtFairValuePeriodIncreaseDecrease	-1993000
CY2016Q1	us-gaap	Servicing Asset At Fair Value Period Increase Decrease ServicingAssetAtFairValuePeriodIncreaseDecrease	-11415000
CY2016Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	61071000
CY2017Q1	pmt	Fair Value Of Mortgage Servicing Rights Pledged To Secure Note Payable FairValueOfMortgageServicingRightsPledgedToSecureNotePayable	68812000
CY2016Q1	pmt	Fair Value Of Mortgage Servicing Rights Pledged To Secure Note Payable FairValueOfMortgageServicingRightsPledgedToSecureNotePayable	64136000
CY2017Q1	us-gaap	Contractually Specified Servicing Fees Amount ContractuallySpecifiedServicingFeesAmount	37281000
CY2016Q1	us-gaap	Contractually Specified Servicing Fees Amount ContractuallySpecifiedServicingFeesAmount	27779000
CY2017Q1	us-gaap	Late Fee Income Generated By Servicing Financial Assets Amount LateFeeIncomeGeneratedByServicingFinancialAssetsAmount	1037000
CY2016Q1	us-gaap	Late Fee Income Generated By Servicing Financial Assets Amount LateFeeIncomeGeneratedByServicingFinancialAssetsAmount	958000
CY2017Q1	us-gaap	Ancillary Fee Income Generated By Servicing Financial Assets Amount AncillaryFeeIncomeGeneratedByServicingFinancialAssetsAmount	187000
CY2016Q1	us-gaap	Ancillary Fee Income Generated By Servicing Financial Assets Amount AncillaryFeeIncomeGeneratedByServicingFinancialAssetsAmount	136000
CY2017Q1	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	38505000
CY2016Q1	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	28873000
CY2017Q1	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate During Period SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateDuringPeriod	0.0257
CY2016Q1	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate During Period SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateDuringPeriod	0.0223
CY2017Q1	pmt	Assets Sold Under Agreements To Repurchase Average Balance AssetsSoldUnderAgreementsToRepurchaseAverageBalance	3267864000
CY2016Q1	pmt	Assets Sold Under Agreements To Repurchase Average Balance AssetsSoldUnderAgreementsToRepurchaseAverageBalance	2797301000
CY2017Q1	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	22182000
CY2016Q1	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	20412000
CY2017Q1	pmt	Asset Sold Under Agreements To Repurchase Maximum Daily Amount Outstanding AssetSoldUnderAgreementsToRepurchaseMaximumDailyAmountOutstanding	4330825000
CY2016Q1	pmt	Asset Sold Under Agreements To Repurchase Maximum Daily Amount Outstanding AssetSoldUnderAgreementsToRepurchaseMaximumDailyAmountOutstanding	3577236000
CY2017Q1	pmt	Assets Sold Under Agreements To Repurchase AssetsSoldUnderAgreementsToRepurchase	3500667000
CY2016Q4	pmt	Assets Sold Under Agreements To Repurchase AssetsSoldUnderAgreementsToRepurchase	3784685000
CY2016Q1	pmt	Representations And Warranties Recovery RepresentationsAndWarrantiesRecovery	0
CY2016Q1	pmt	Representations And Warranties Liability RepresentationsAndWarrantiesLiability	18712000
CY2017Q1	pmt	Guarantee Obligations Recourse Provision Unpaid Principal Balance Of Mortgage Loans Subject To Representations And Warranties GuaranteeObligationsRecourseProvisionUnpaidPrincipalBalanceOfMortgageLoansSubjectToRepresentationsAndWarranties	58797849000
CY2016Q1	pmt	Guarantee Obligations Recourse Provision Unpaid Principal Balance Of Mortgage Loans Subject To Representations And Warranties GuaranteeObligationsRecourseProvisionUnpaidPrincipalBalanceOfMortgageLoansSubjectToRepresentationsAndWarranties	43464887000
CY2017Q1	pmt	Mortgage Loans Acquired For Sale Outstanding Contractual Purchase Commitments MortgageLoansAcquiredForSaleOutstandingContractualPurchaseCommitments	1464906000
CY2017Q1	pmt	Commitments To Fund Deposits Securing Credit Risk Transfer Agreements CommitmentsToFundDepositsSecuringCreditRiskTransferAgreements	149220000
CY2017Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	139000
CY2017Q1	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate At Period End SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateAtPeriodEnd	0.0240
CY2016	pmt	Securities Sold Under Agreements To Repurchase Weighted Average Interest Rate At Period End SecuritiesSoldUnderAgreementsToRepurchaseWeightedAverageInterestRateAtPeriodEnd	0.0270
CY2017Q1	pmt	Assets Sold Under Agreements Available Borrowing Capacity Committed AssetsSoldUnderAgreementsAvailableBorrowingCapacityCommitted	380298000
CY2016	pmt	Assets Sold Under Agreements Available Borrowing Capacity Committed AssetsSoldUnderAgreementsAvailableBorrowingCapacityCommitted	518932000
CY2017Q1	pmt	Securities Sold Under Agreements Available Borrowing Capacity Uncommitted SecuritiesSoldUnderAgreementsAvailableBorrowingCapacityUncommitted	1247941000
CY2016	pmt	Securities Sold Under Agreements Available Borrowing Capacity Uncommitted SecuritiesSoldUnderAgreementsAvailableBorrowingCapacityUncommitted	1092253000
CY2017Q1	pmt	Securities Sold Under Agreements Available Borrowing Capacity SecuritiesSoldUnderAgreementsAvailableBorrowingCapacity	1628239000
CY2016	pmt	Securities Sold Under Agreements Available Borrowing Capacity SecuritiesSoldUnderAgreementsAvailableBorrowingCapacity	1611185000
CY2017Q1	us-gaap	Good Faith And Margin Deposits With Broker Dealers GoodFaithAndMarginDepositsWithBrokerDealers	16690000
CY2016Q4	us-gaap	Good Faith And Margin Deposits With Broker Dealers GoodFaithAndMarginDepositsWithBrokerDealers	29634000
CY2017Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3500667000
CY2017Q1	pmt	Repurchase Agreements Weighted Average Maturity Period RepurchaseAgreementsWeightedAverageMaturityPeriod	P3Y8M12D
CY2016Q1	pmt	Federal Home Loan Bank Advances Weighted Average Interest Rate During Period FederalHomeLoanBankAdvancesWeightedAverageInterestRateDuringPeriod	0.0049
CY2016Q1	us-gaap	Federal Home Loan Bank Advances Activity For Year Average Balance Of Agreements Outstanding FederalHomeLoanBankAdvancesActivityForYearAverageBalanceOfAgreementsOutstanding	98038000
CY2016Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	122000
CY2016Q1	pmt	Federal Home Loan Bank Advances Activity For Year Maximum Daily Amount Outstanding FederalHomeLoanBankAdvancesActivityForYearMaximumDailyAmountOutstanding	201130000
CY2017Q1	pmt	Note Payable Weighted Average Interest Rate During Period NotePayableWeightedAverageInterestRateDuringPeriod	0.0513
CY2016Q1	pmt	Note Payable Weighted Average Interest Rate During Period NotePayableWeightedAverageInterestRateDuringPeriod	0.0459
CY2017Q1	pmt	Note Payable Average Balance During Period NotePayableAverageBalanceDuringPeriod	260384000
CY2016Q1	pmt	Note Payable Average Balance During Period NotePayableAverageBalanceDuringPeriod	213616000
CY2017Q1	pmt	Note Payable Interest Expense During Period NotePayableInterestExpenseDuringPeriod	4305000
CY2016Q1	pmt	Note Payable Interest Expense During Period NotePayableInterestExpenseDuringPeriod	3344000
CY2017Q1	pmt	Notes Payable Gross NotesPayableGross	100106000
CY2016Q4	pmt	Notes Payable Gross NotesPayableGross	275106000
CY2017Q1	pmt	Note Payable Weighted Average Interest Rate NotePayableWeightedAverageInterestRate	0.0512
CY2016	pmt	Note Payable Weighted Average Interest Rate NotePayableWeightedAverageInterestRate	0.0473
CY2017Q1	pmt	Mortgage Servicing Rights Secured Notes Payable MortgageServicingRightsSecuredNotesPayable	686759000
CY2016Q4	pmt	Mortgage Servicing Rights Secured Notes Payable MortgageServicingRightsSecuredNotesPayable	656567000
CY2017Q1	pmt	Convertible Debt Average Balance During Period ConvertibleDebtAverageBalanceDuringPeriod	250000000
CY2016Q1	pmt	Convertible Debt Average Balance During Period ConvertibleDebtAverageBalanceDuringPeriod	250000000
CY2017Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	250000000
CY2016Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	250000000
CY2015Q4	pmt	Representations And Warranties Liability RepresentationsAndWarrantiesLiability	20171000
CY2017Q1	pmt	Provisions For Representations And Warranties Losses ProvisionsForRepresentationsAndWarrantiesLosses	673000
CY2016Q1	pmt	Provisions For Representations And Warranties Losses ProvisionsForRepresentationsAndWarrantiesLosses	571000
CY2017Q1	pmt	Reduction In Liability Due To Change In Estimate ReductionInLiabilityDueToChangeInEstimate	-4576000
CY2016Q1	pmt	Reduction In Liability Due To Change In Estimate ReductionInLiabilityDueToChangeInEstimate	-1724000
CY2017Q1	pmt	Representations And Warranties Losses Incurred RepresentationsAndWarrantiesLossesIncurred	0
CY2016Q1	pmt	Representations And Warranties Losses Incurred RepresentationsAndWarrantiesLossesIncurred	306000
CY2017Q1	pmt	Representations And Warranties Recovery RepresentationsAndWarrantiesRecovery	0
CY2016Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5156000
CY2017Q1	pmt	Stock Repurchase Program Cumulative Number Of Shares Repurchased StockRepurchaseProgramCumulativeNumberOfSharesRepurchased	8552000
CY2017Q1	pmt	Stock Repurchase Program Cost Of Cumulative Shares Repurchased StockRepurchaseProgramCostOfCumulativeSharesRepurchased	117015000
CY2017Q1	pmt	Agreement Effective Date AgreementEffectiveDate	2013-02-01
CY2017Q1	us-gaap	Payment For Incentive Fee PaymentForIncentiveFee	10
CY2017Q1	us-gaap	Performance Fees PerformanceFees	100
CY2017Q1	pmt	Contingent Underwriting Fee Payments To Underwriters ContingentUnderwritingFeePaymentsToUnderwriters	0
CY2016Q1	pmt	Contingent Underwriting Fee Payments To Underwriters ContingentUnderwritingFeePaymentsToUnderwriters	0
CY2017Q1	pmt	Average Balance During Period For Servicing Assets Portfolio AverageBalanceDuringPeriodForServicingAssetsPortfolio	57927056000
CY2016Q1	pmt	Average Balance During Period For Servicing Assets Portfolio AverageBalanceDuringPeriodForServicingAssetsPortfolio	43253977000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	259610
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	330076
CY2017Q1	pmt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue	4003000
CY2016Q1	pmt	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodGrantDateFairValue	4050000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	152701
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	76048
CY2017Q1	pmt	Share Based Compensation Cash And Noncash ShareBasedCompensationCashAndNoncash	1527000
CY2016Q1	pmt	Share Based Compensation Cash And Noncash ShareBasedCompensationCashAndNoncash	1048000
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.271
CY2016Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.313
CY2017Q1	pmt	Other Operating Income Loss Net OtherOperatingIncomeLossNet	6055000
CY2017Q1	pmt	Loan Fulfillment Servicing And Management Fees Payable To Affiliate LoanFulfillmentServicingAndManagementFeesPayableToAffiliate	27056000
CY2017Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9802000
CY2016Q1	pmt	Other Operating Income Loss Net OtherOperatingIncomeLossNet	3149000
CY2016Q1	pmt	Loan Fulfillment Servicing And Management Fees Payable To Affiliate LoanFulfillmentServicingAndManagementFeesPayableToAffiliate	24388000
CY2016Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	11432000
CY2016Q1	us-gaap	Assets Assets	5820440000
CY2017Q1	us-gaap	Interest Paid InterestPaid	35838000
CY2016Q1	us-gaap	Interest Paid InterestPaid	36594000
CY2017Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	31000
CY2016Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	175000
CY2017Q1	pmt	Receipt Of Mortgage Servicing Rights As Proceeds From Sales Of Loans ReceiptOfMortgageServicingRightsAsProceedsFromSalesOfLoans	58688000
CY2016Q1	pmt	Receipt Of Mortgage Servicing Rights As Proceeds From Sales Of Loans ReceiptOfMortgageServicingRightsAsProceedsFromSalesOfLoans	36162000
CY2017Q1	pmt	Increase Decrease Of Excess Servicing Spread Recapture Receivable From Affiliates IncreaseDecreaseOfExcessServicingSpreadRecaptureReceivableFromAffiliates	1573000
CY2016Q1	pmt	Increase Decrease Of Excess Servicing Spread Recapture Receivable From Affiliates IncreaseDecreaseOfExcessServicingSpreadRecaptureReceivableFromAffiliates	1911000
CY2017Q1	pmt	Capitalization Of Servicing Advances Pursuant To Mortgage Loan Modifications CapitalizationOfServicingAdvancesPursuantToMortgageLoanModifications	6349000
CY2016Q1	pmt	Capitalization Of Servicing Advances Pursuant To Mortgage Loan Modifications CapitalizationOfServicingAdvancesPursuantToMortgageLoanModifications	0
CY2017Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	31652000
CY2016Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	32695000
CY2017Q1	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	2500000
CY2017Q1	us-gaap	Loans Receivable Basis Spread On Variable Rate LoansReceivableBasisSpreadOnVariableRate	0.0025
CY2017Q1	pmt	Number Of Residential Mortgage Loans Served NumberOfResidentialMortgageLoansServed	1-4

Files In Submission

Name	View Source	Status
0001564590-17-009925-index-headers.html	Edgar Link	pending
0001564590-17-009925-index.html	Edgar Link	pending
0001564590-17-009925.txt	Edgar Link	pending
0001564590-17-009925-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pmt-10q_20170331.htm	Edgar Link	pending
pmt-20170331.xml	Edgar Link	completed
pmt-20170331.xsd	Edgar Link	pending
pmt-20170331_cal.xml	Edgar Link	unprocessable
pmt-20170331_def.xml	Edgar Link	unprocessable
pmt-20170331_lab.xml	Edgar Link	unprocessable
pmt-20170331_pre.xml	Edgar Link	unprocessable
pmt-ex1080_1040.htm	Edgar Link	pending
pmt-ex1088_1039.htm	Edgar Link	pending
pmt-ex311_11.htm	Edgar Link	pending
pmt-ex312_12.htm	Edgar Link	pending
pmt-ex321_18.htm	Edgar Link	pending
pmt-ex322_17.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMT
PennyMac Mortgage Investment Trust Stock $pmt

2017 Q1 Form 10-Q Financial Statement

#000156459017009925 Filed on May 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMT PennyMac Mortgage Investment Trust Stock $pmt

2017 Q1 Form 10-Q Financial Statement

#000156459017009925 Filed on May 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMT
PennyMac Mortgage Investment Trust Stock $pmt